

share
4-Hydroxycephalotaxine CAS NO 84567-08-8
Unit Price:
CAS No.:84567-08-8
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
4-Hydroxycephalotaxine is a key alkaloid derivative of the Cephalotaxus genus, valued for its role as a critical intermediate in pharmaceutical research and development. This compound is of significant interest for its structural relationship to bioactive natural products, particularly in the study of novel therapeutic agents. It is primarily utilized by research institutions and pharmaceutical companies engaged in the synthesis of complex molecules and the investigation of new drug candidates.
Application
- Pharmaceutical Intermediate: Serves as a crucial building block in the synthesis of complex alkaloids and potential drug candidates.
- Biochemical Research: Used as a reference standard or reagent in studies exploring plant alkaloid biosynthesis and biological activity.
- Medicinal Chemistry: Employed in structure-activity relationship (SAR) studies to develop new therapeutic compounds with improved efficacy.
- Academic Research: Utilized in university and institutional labs for chemical education and natural product chemistry projects.
- Analytical Standard: Acts as a high-purity standard for qualitative and quantitative analysis (e.g., HPLC, LC-MS) in quality control laboratories.
Basic Information
| Product Name | 4-Hydroxycephalotaxine |
| CAS No. | 84567-08-8 |
| Molecular Formula | C18H21NO5 |
| Molecular Weight | 331.37 g/mol |
| Synonyms | 4-Hydroxycephalotaxine; Cephalotaxine, 4-hydroxy-; 4-Hydroxy-cephalotaxine; 4-Hydroxycephalotaxin; (1S,3aR,14bS)-1,2,3,3a,4,5,7,14b-Octahydro-1-hydroxy-6-methoxy-3a,8-dimethylfuro[3',4':6,7]azepino[1,2-b]isoquinoline-3,9-dione |
| EINECS | Contact for details |
Quality Control
Our 4-Hydroxycephalotaxine is produced and tested under a rigorous quality management system. Each batch is analyzed to ensure high purity and consistency, with specifications suitable for research and development applications. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment to guarantee traceability and compliance with your project requirements.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This product is light-sensitive and should be handled accordingly to maintain stability.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white powder |
| Identification (IR) | Conforms to structure |
| Assay (HPLC) | ≥ 95.0% |
| Related Substances (HPLC) | Total impurities ≤ 5.0% |
| Loss on Drying | ≤ 2.0% |
| Residue on Ignition | ≤ 0.5% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Rutaecarpine CAS NO 84-26-4


1,7-Dimethylxanthine CAS NO 611-59-6


Capsaicin CAS NO 404-86-4


Muscimol Hydrate CAS NO 18174-72-6


Catharanthine CAS NO 2468-21-5


Muscimol CAS NO 2763-96-4


6-Methoxyharmalan CAS NO 3589-73-9


Mesembrine CAS NO 468-53-1


Dihydroberberine CAS NO 483-15-8


Nicotine CAS NO 54-11-5


Quinine Hydrochloride Dihydrate CAS NO 6119-47-7


Arecoline CAS NO 63-75-2


Tetrahydropapaverine Hydrochloride CAS NO 6429-04-5


L-Hyoscyamine CAS NO 101-31-5


14,17-Dihydro-3-Methoxy-16(15H)-Oxaerythrinan-15-One (3Beta)- CAS NO 115-36-6


Sinomenine CAS NO 115-53-7


Benzog-1,3-Benzodioxolo5,6-Aquinolizinium, 5,6-Dihydro-9,10-Dimethoxy-, Hydroxide CAS NO 117-74-8


Cinchonine CAS NO 118-10-5


Sabadine CAS NO 124-80-1


Protoveratrine B CAS NO 124-97-0
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






